ADVFN - ニュース

S&P 500

5,307.01

-0.27%

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	20 : 01	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:CLGDF	Aris Mining Corporation (PK)
2024/05/23	20 : 00	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:KRMD	KORU Medical Systems Inc
2024/05/23	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:KZIA	Kazia Therapeutics Ltd
2024/05/23	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGMT	Sagiment Biosciences Inc
2024/05/23	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:EVGN	Evogene Ltd
2024/05/23	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HLNE	Hamilton Lane Inc
2024/05/23	20 : 00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MSSV	Meso Numismatics Inc (PK)
2024/05/23	20 : 00	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	USOTC:LKNCY	Luckin Coffee Inc (PK)
2024/05/23	20 : 00	GlobeNewswire Inc.	Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Protein Degradation in Focus Symposium
2024/05/23	20 : 00	GlobeNewswire Inc.	ARCPOINT TO HOST CONFERENCE CALL TO DISCUSS 2024 Q1 FINANCIAL RESULTS	TSXV:ARC	ARCpoint Inc
2024/05/23	20 : 00	Business Wire	Kinaxis sélectionné comme solution d'orchestration de la chaîne d'approvisionnement par Intercos Group	TSX:KXS	Kinaxis Inc
2024/05/23	20 : 00	GlobeNewswire Inc.	Leading Proxy Advisory Firm ISS Recommends that Mayfair Gold Shareholders Vote FOR All Company Nominees	TSXV:MFG	Mayfair Gold Corp
2024/05/23	20 : 00	GlobeNewswire Inc.	Immersive Fishing and Boating Sim ‘Ships at Sea’ from Misc Games Available Now in PC Early Access
2024/05/23	20 : 00	Business Wire	Intercos Group wählt Kinaxis als Lösung zur Orchestrierung der Lieferkette	TSX:KXS	Kinaxis Inc
2024/05/23	20 : 00	GlobeNewswire Inc.	atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors	NASDAQ:ATAI	ATAI Life Sciences NV
2024/05/23	20 : 00	GlobeNewswire Inc.	Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’	NASDAQ:TLRY	Tilray Brands Inc
2024/05/23	20 : 00	GlobeNewswire Inc.	Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’	TSX:TLRY	Tilray Brands Inc
2024/05/23	20 : 00	Business Wire	SSR Mining Announces Closing of Sale of San Luis Project to Highlander Silver	ASX:SSR	SSR Mining Inc
2024/05/23	20 : 00	Business Wire	PureTech to Present at the Jefferies Global Healthcare Conference	NASDAQ:PRTC	PureTech Health PLC
2024/05/23	20 : 00	GlobeNewswire Inc.	Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 Medications (Low-Cost Semaglutide), NAD+ and more	SO6
2024/05/23	20 : 00	GlobeNewswire Inc.	Macerich Launches Path-Forward Plan	NYSE:MAC	Macerich Co
2024/05/23	20 : 00	GlobeNewswire Inc.	Script Runner launches Canada’s first AI-powered drone delivery service, revolutionizing healthcare access for remote communities
2024/05/23	20 : 00	GlobeNewswire Inc.	West Red Lake Gold Strengthens Investor Relations Team	TSXV:WRLG	West Red Lake Gold Mines Ltd
2024/05/23	20 : 00	Business Wire	Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing	NASDAQ:BCYC	Bicycle Therapeutics PLC
2024/05/23	20 : 00	Business Wire	CatalYm to Present Positive New Phase 2a Follow-up Data on GDF-15 Neutralizing Antibody Visugromab in Advanced NSCLC, Urothelial, and Hepatocellular Cancer at the 2024 ASCO Annual Meeting
2024/05/23	20 : 00	GlobeNewswire Inc.	Rivalry to Report First Quarter 2024 Results on May 30	TSXV:RVLY	Rivalry Corp
2024/05/23	20 : 00	GlobeNewswire Inc.	OTC Markets Group Welcomes Direct Selling Acquisition Corp. to OTCQX	NYSE:DSAQ	Direct Selling Acquisition Corp
2024/05/23	20 : 00	GlobeNewswire Inc.	Pneumagen Presents Positive Phase 2 Influenza Human Challenge Study data on Neumifil, its Broad-Spectrum Antiviral Drug, at the American Thoracic Society (ATS) 2024 Conference
2024/05/23	20 : 00	Business Wire	Tango Therapeutics Announces Discontinuation of TNG348 Program	NASDAQ:TNGX	Tango Therapeutics Inc
2024/05/23	20 : 00	GlobeNewswire Inc.	DraftKings Completes Acquisition of Jackpocket	NASDAQ:DKNG	DraftKings Inc